反応式
I[C:2]1[CH:3]=[C:4]([CH2:8][C@H:9]([NH:18][C:19](=[O:25])[O:20][C:21]([CH3:24])([CH3:23])[CH3:22])[C:10](=[O:17])[N:11]2[CH2:16][CH2:15][CH2:14][CH2:13][CH2:12]2)[CH:5]=[CH:6][CH:7]=1.[C:26]([O:32][C:33]([CH3:36])([CH3:35])[CH3:34])(=[O:31])[CH2:27][CH2:28][C:29]#[CH:30].C(N(CC)CC)C.C(Cl)Cl>CN(C=O)C.CCCCCC.C(OCC)(=O)C.[Cu]I.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2]>[C:21]([O:20][C:19]([NH:18][C@H:9]([C:10](=[O:17])[N:11]1[CH2:16][CH2:15][CH2:14][CH2:13][CH2:12]1)[CH2:8][C:4]1[CH:3]=[C:2]([C:30]#[C:29][CH2:28][CH2:27][C:26]([O:32][C:33]([CH3:36])([CH3:35])[CH3:34])=[O:31])[CH:7]=[CH:6][CH:5]=1)=[O:25])([CH3:24])([CH3:23])[CH3:22]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 4
実験手順
tert-Butyl (S)-(3-(3-iodophenyl)-1-oxo-1-(piperidin-1-yl)propan-2-yl)carbamate (Compound SP418, Boc-Phe(3-I)-pip) (5.00 g, 10.91 mmol), tert-butyl pent-4-ynoate (3.36 g, 21.82 mmol) and triethylamine (4.56 ml, 32.7 mmol) were dissolved in DMF (50.0 ml), CuI (0.104 g, 0.545 mmol) and Pd(dppf)Cl2.CH2Cl2 (0.449 g, 0.545 mmol) were added and the mixture was stirred at room temperature for 5 hours. The reaction solution was diluted with hexane/ethyl acetate (1/1) and washed with a saturated aqueous ammonium chloride solution and brine. The organic layer was dried over anhydrous magnesium sulfate, and then filtered and concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (hexane:ethyl acetate=100:0-60:40) to afford the title compound (Compound SP430) (4.84 g, 92%).
後処理
- washwashed with a saturated aqueous ammonium chloride solution and brine
- dry with materialThe organic layer was dried over anhydrous magnesium sulfate
- filtrationfiltered
- concentrationconcentrated under reduced pressure
- customthe resulting residue was purified by silica gel column chromatography (hexane:ethyl acetate=100:0-60:40)
出典と根拠
- ORDレコード
- ord-9e302d7ad16f48638b88abfe84ec7c12
- 出典データセット
- uspto-grants-2016_08
- 特許番号
- US09409952B2
関連ノート
読み込み中…